Assessing the IMpact of Alopecia Areata (AA) on PatIents’ and CaregiverS’ in Australia (MARISSA)

Pfizer Australia Pty Ltd0 个研究点目标入组 428 人开始时间: 2023年2月16日最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•Patient survey
•Self-reported medically confirmed diagnosis of AA for at least 3 months before the survey completion date (assessed via online screener)
•For adolescents aged 12-17 years old, consent from parents/guardians and assent from the patients (assent form 12-14 years and 15-17 years) will be required, this will be obtained sequentially).
•Caregiver survey
•Parent or legal guardian of a patient aged 12-17 years with self-reported medically confirmed diagnosis of AA for at least 3 months before the survey completion date

•Patients with a medical diagnosis of any form of cancer in the past 5 years or with a medical diagnosis of androgenetic alopecia (AGA) and patient or dependant with a self-reported medically confirmed diagnosis of AA for less than 3 months before the survey completion date
•Adolescents can only participate if caregiver has provided contact details on adolescent behalf

发起方